Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Nina Rosenqvist"'
Publikováno v:
Cell Transplantation, Vol 14 (2005)
The use of ex vivo gene therapy in the central nervous system has so far suffered from transgene downregulation. Condensation of the transgenic sequences has been proposed to be a mechanism involved in this silencing. In this study we inhibited eithe
Externí odkaz:
https://doaj.org/article/d589f943154d422d90e14576b31b6c51
Autor:
Anne-Marie Jacobsen, Nico C. van de Merbel, Dorte K. Ditlevsen, Ketil Tvermosegaard, Frank Schalk, Wietske Lambert, Christoffer Bundgaard, Jan T. Pedersen, Nina Rosenqvist
Publikováno v:
Journal of the American Society for Mass Spectrometry. 34:441-451
Autor:
Lone Helboe, Nina Rosenqvist, Christiane Volbracht, Lars Ø. Pedersen, Jan T. Pedersen, Søren Christensen, Jan Egebjerg, Claus T. Christoffersen, Benny Bang-Andersen, Thomas G. Beach, Geidy E. Serrano, Jeppe Falsig
Publikováno v:
Journal of Alzheimer's Disease. 88:207-228
Background: Deposits of hyperphosphorylated tau fibrils are hallmarks of a broad spectrum of tauopathies, including Alzheimer’s disease (AD). Objective: To investigate heterogeneity of tau pathology across brain extracts from a broad selection of d
Publikováno v:
Journal of Neuroscience Research. 84:58-67
In this study we have developed and validated a novel approach of transgene regulation in the brain. By using lentiviral vectors that incorporate promoters of genes that are up-regulated during different pathological states, we were able to regulate
Autor:
Christofer Samuelsson, Nina Rosenqvist, Jens Johansen, Caroline Hård af Segerstad, Cecilia Lundberg
Publikováno v:
The Journal of Gene Medicine. 4:248-257
Background Ex vivo gene therapy in the central nervous system (CNS) holds great promise for diseases such as the neurodegenerative disorders. However, achieving stable, long-term transgene expression in grafted cells has proven problematic. This stud
Publikováno v:
BMC Biotechnology, Vol 9, Iss 1, p 13 (2009)
BMC Biotechnology
BMC Biotechnology
Background Lentiviral vectors hold great promise as gene transfer vectors in gene therapeutic settings. However, problems related to the risk of insertional mutagenesis, transgene silencing and positional effects have stalled the use of such vectors
Publikováno v:
Experimental cell research. 298(2)
Transplantation of genetically manipulated cells to the central nervous system holds great promise for the treatment of several severe neurological disorders. The success of this strategy relies on sufficient levels of transgene expression after tran
Publikováno v:
International review of neurobiology. 55
Publisher Summary This chapter describes the different types of lentiviral vectors and discusses their use for gene transfer to the central nervous system (CNS). The lentiviral family consists of several viruses, both primate and nonprimate. The most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad8d161653426e84d8e7362b0baa5914
https://doi.org/10.1016/s0074-7742(03)01004-3
https://doi.org/10.1016/s0074-7742(03)01004-3
Autor:
Nina, Rosenqvist, Caroline, Hård Af Segerstad, Christofer, Samuelsson, Jens, Johansen, Cecilia, Lundberg
Publikováno v:
The journal of gene medicine. 4(3)
Ex vivo gene therapy in the central nervous system (CNS) holds great promise for diseases such as the neurodegenerative disorders. However, achieving stable, long-term transgene expression in grafted cells has proven problematic. This study reports t